Dr Reddy’s To Raise $250-300 Million From Overseas To Fund Buys
Just when we were talking of M&As in the pharma space, Dr Reddy’s Laboratories, the Hyderabad-based biggie, is raising $250-300 million from overseas. This will be used for funidng inorganic growth. The company is believed to be looking at issuing American Depository Receipts (ADRs) worth around $250-300 million, says a PTI article. Dr Reddy’s has already completed the funding for its $570 million-acquisition of Germany’s Betapharm, which was made earlier this year.
